Discriminating nodular pulmonary alveolar proteinosis from lung adenocarcinoma with radiomic model and multimodal model

Interstitial Lung Disease

Recurrent pulmonary alveolar proteinosis after lung transplantation: a case series

Respir Med

Westhölter D, Opitz M, Rawitzer J, Greer M, Wessendorf T, Cordes S, Costabel U, Taube C, Bonella F

doi: 10.1016/j.rmed.2025.108167

Further Publications

A case of EGFR-positive lung adenocarcinoma that once transformed into small cell carcinoma but worsened into adenocarcinoma again

Respir Med Case Rep

Tanaka S, Yokota K, Yoshimura N, Tobita S, Yaga M, Ueno K

doi: 10.1016/j.rmcr.2025.102271

Further Publications

EGFR-mutant lung adenocarcinoma transformed into small cell Lung cancer: A case report and literatures review

Respir Med Case Rep

Chen J, Huang H, Zhong P, Peng S, Zhu X, Ding X, Wang F, Kong P, Song T, Lu Z, Chen L

doi: 10.1016/j.rmcr.2025.102219

Further Publications

Neoadjuvant chemoimmunotherapy in non-small-cell lung cancer patients: Effects on pulmonary function and incidence of postoperative pulmonary complications-a multicenter real-world study

Eur J Cardiothorac Surg

Zhang J, Feng Y, Dai S, Xu G, Cheng B, Jiang L, Xue LP, Liang W, Tang J

doi: 10.1093/ejcts/ezaf351

Lung Cancer

Clinical, Dosimetric and Radiomic Features Predictive of Lung Toxicity After (Chemo)Radiotherapy

Clin Lung Cancer

Evin C, Razakamanantsoa L, Gardavaud F, Papillon L, Boulaala H, Ferrer L, Gallinato O, Colin T, Moussa SB, Harfouch Y, Foulquier JN, Guillerm S, Bibault JE, Huguet F, Wagner M, Rivin Del Campo E

doi: 10.1016/j.cllc.2024.11.003

Lung Cancer

Impact of TP53 Co-Mutation on Clinicopathological Features, Prognosis, Recurrence Patterns, and the Efficacy of EGFR-TKI Treatment After Recurrence in Resected Early-Stage EGFR-Mutated Lung Adenocarcinoma

Clin Lung Cancer

Masuda T, Katsumata S, Isaka M, Serizawa M, Kawata T, Asami M, Yamaguchi D, Matsushima K, Hayasaka K, Kojima H, Yokomakura N, Konno H, Nagashima T, Urakami K, Yamaguchi K, Ohde Y

doi: 10.1016/j.cllc.2025.04.009

Lung Cancer

Immune Checkpoint Inhibitor Without Pemetrexed for First-line Maintenance Therapy in Advanced Lung Adenocarcinoma: A Real-World Retrospective Study

Clin Lung Cancer

Gao M, Nie Y, Wang T, Jing F, Zhang F, Tao H, Ma J, Wang L, Hu Y

doi: 10.1016/j.cllc.2025.08.011

Lung Cancer

Pattern of brain metastases and survival in lung adenocarcinoma with KRAS or EFGR mutation

Lung Cancer

Faehling M, Fallscheer S, Schmiederer J, Sträter J, Christopoulos P, Lengerke C, Seifarth H

doi: 10.1016/j.lungcan.2025.108803

Lung Cancer

Survival outcomes of patients with uncommon EGFR mutations in surgically resected lung adenocarcinoma: A multi-institutional real-world database study (CReGYT-01 EGFR study)

Lung Cancer

Hayasaka K, Shimokawa M, Haratake N, Notsuda H, Katsumata S, Hamada A, Nomura K, Fujino K, Yoshikawa M, Suzawa K, Shien K, Suda K, Ohara S, Fukuda S, Kinoshita I, Takamori S, Muto S, Takanashi Y, Mizuno K, Hayakawa T, Sekihara K, Toda M, Matsuo S, Takegahara K, Hashimoto M, Nakahashi K, Endo M, Ozawa H, Fujikawa R, Tomioka Y, Namba K, Matsubara T, Suzuki J, Watanabe H, Takada K, Hoshino H, Kaiho T, Toyoda T, Shiono S, Soh J, Ohde Y, Okada Y

doi: 10.1016/j.lungcan.2026.108908

Related content

Recurrent pulmonary alveolar proteinosis after lung transplantation: a case series

A case of EGFR-positive lung adenocarcinoma that once transformed into small cell carcinoma but worsened into adenocarcinoma again

EGFR-mutant lung adenocarcinoma transformed into small cell Lung cancer: A case report and literatures review

Neoadjuvant chemoimmunotherapy in non-small-cell lung cancer patients: Effects on pulmonary function and incidence of postoperative pulmonary complications-a multicenter real-world study

Clinical, Dosimetric and Radiomic Features Predictive of Lung Toxicity After (Chemo)Radiotherapy

Impact of TP53 Co-Mutation on Clinicopathological Features, Prognosis, Recurrence Patterns, and the Efficacy of EGFR-TKI Treatment After Recurrence in Resected Early-Stage EGFR-Mutated Lung Adenocarcinoma

Immune Checkpoint Inhibitor Without Pemetrexed for First-line Maintenance Therapy in Advanced Lung Adenocarcinoma: A Real-World Retrospective Study

Pattern of brain metastases and survival in lung adenocarcinoma with KRAS or EFGR mutation

Survival outcomes of patients with uncommon EGFR mutations in surgically resected lung adenocarcinoma: A multi-institutional real-world database study (CReGYT-01 EGFR study)